| 发明名称 |
CDR-MODIFIED ANTI-SIGLEC-15 ANTIBODY |
| 摘要 |
Provided is a pharmaceutical composition for the treatment and/or prophylaxis of abnormal bone metabolism targeting a protein encoded by a gene strongly expressed in osteoclasts. Specifically provided is a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation, and the like. |
| 申请公布号 |
SG11201405966P(A) |
申请公布日期 |
2014.11.27 |
| 申请号 |
SG11201405966P |
申请日期 |
2013.03.29 |
| 申请人 |
DAIICHI SANKYO COMPANY,LIMITED |
发明人 |
HIRUMA, YOSHIHARU;KIMURA, TAKAKO;SHIMIZU, HIRONARI |
| 分类号 |
C12N15/09;A61K39/395;A61P1/02;A61P7/00;A61P19/00;A61P19/02;A61P19/10;A61P29/00;A61P35/00;A61P43/00;C07K16/18;C07K16/46;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/08 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
